The AI engine Fit Assessment
BetaPepticom leverages machine learning to discover innovative peptide therapeutics, optimizing the drug discovery process and expanding therapeutic options.
Blurb
HQ Location
Founded
Employees
Total funding raised
Funding Status
Pepticom is a unique Artificial Intelligence (AI) platform company with disruptive technology for peptide discovery. The platform is based on research carried out in the Hebrew University and extensively developed further by the company.
Pepticom’s disruptive technology allows for the discovery of quantity and quality innovative peptides and other molecules at a fraction of the time and cost of the traditional laboratory discovery methods. The peptide discovered can be used as drugs, in agriculture and animal well-being.
Pepticom is engaged in various discovery projects such as ADAMA in the field of agriculture and with other big companies in the Pharmaceutical filed.